The study supports the use of low-dose pulse CYC as induction therapy of recently deteriorated SSc-ILD. Moreover, it suggests that azathioprine should be administered to CYC-responsive patients but does not show any definite effect of micophenolic acid in unresponsive patients. ScienceDirect, 09/08/2014. (Also see: Immunosuppressants)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.